Nihilent launches nSEPIA Beta, introduces AI-driven emotional wellness platform
AI-powered platform uses real-time emotion scanning and personalised interventions to make emotional wellness measurable and actionable
AI-powered platform uses real-time emotion scanning and personalised interventions to make emotional wellness measurable and actionable
Multi-stakeholder initiative highlights inclusive sports pathways, honours neurodivergent athletes, and calls for systemic reforms
The Pharmaceuticals portfolio and pipeline are more promising than perhaps ever before
Shares issued under ESOP 2008 and MESOP 2018 plans following exercise of vested stock options, in compliance with SEBI disclosure norms
Veteran pharma leader brings 33+ years of experience to drive operational excellence in formulation business
Deal includes 13 branded generic products across 55+ countries; acquisition expected to strengthen global anti-infective portfolio and expand regulated market presence
Collaboration integrates SmartChip PCR technology with cloud-based analytics to enable faster, standardised monitoring of antimicrobial resistance
New facility offers genetic testing, counselling and personalised treatment plans to enable early diagnosis and precision-led care
The study evaluated oral semaglutide in young patients with type 2 diabetes and found it delivered a superior reduction in HbA1c
The transition from an outsourced MRI model to an in-house facility marks more than an infrastructure upgrade
Subscribe To Our Newsletter & Stay Updated